Fingolimod News and Research

RSS
Response to COVID-19 boosters in seronegative multiple sclerosis patients

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

Fighting SARS-CoV-2 with nanomedicine

Fighting SARS-CoV-2 with nanomedicine

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Schizophrenia related to abnormal fatty metabolism in the brain

Schizophrenia related to abnormal fatty metabolism in the brain

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

Researchers develop fast diagnostic tool that shows MS patients in relapse

Researchers develop fast diagnostic tool that shows MS patients in relapse

Researchers use structural biology techniques to understand how lipids bind proteins

Researchers use structural biology techniques to understand how lipids bind proteins

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

UA pharmacology professors aim to avoid opioid analgesic tolerance

UA pharmacology professors aim to avoid opioid analgesic tolerance

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

New combination therapy for cancer cells could soon be a reality

New combination therapy for cancer cells could soon be a reality

FDA approves new drug to treat MS in pediatric patients

FDA approves new drug to treat MS in pediatric patients

Novartis PARADIGMS study shows safety and efficacy of new treatment in pediatric MS patients

Novartis PARADIGMS study shows safety and efficacy of new treatment in pediatric MS patients

Established therapeutic drugs may be effective against childhood dementia

Established therapeutic drugs may be effective against childhood dementia

New treatment may hold promise for progressive form of multiple sclerosis, study suggests

New treatment may hold promise for progressive form of multiple sclerosis, study suggests

IUPUI scientists develop new synthetic method to shorten drug discovery and development process

IUPUI scientists develop new synthetic method to shorten drug discovery and development process